{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T15:48:30Z","timestamp":1776872910491,"version":"3.51.2"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T00:00:00Z","timestamp":1764633600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["25K10553"],"award-info":[{"award-number":["25K10553"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP25ama121008"],"award-info":[{"award-number":["JP25ama121008"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP25ama221153"],"award-info":[{"award-number":["JP25ama221153"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP25am0521010"],"award-info":[{"award-number":["JP25am0521010"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP25bm1123027"],"award-info":[{"award-number":["JP25bm1123027"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP25ama221339"],"award-info":[{"award-number":["JP25ama221339"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemistry and Biophysics Reports"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.bbrep.2025.102401","type":"journal-article","created":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T13:20:20Z","timestamp":1765200020000},"page":"102401","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Development of novel anti-CDH1\/E-cadherin monoclonal antibodies for versatile applications"],"prefix":"10.1016","volume":"45","author":[{"given":"Rena","family":"Ubukata","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2646-5132","authenticated-orcid":false,"given":"Hiroyuki","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4158-9208","authenticated-orcid":false,"given":"Mika K.","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5385-8201","authenticated-orcid":false,"given":"Yukinari","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrep.2025.102401_bib1","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1152\/physrev.00004.2010","article-title":"Tissue organization by cadherin adhesion molecules: dynamic molecular and cellular mechanisms of morphogenetic regulation","volume":"91","author":"Niessen","year":"2011","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bbrep.2025.102401_bib2","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1006\/jmbi.2000.3777","article-title":"Phylogenetic analysis of the cadherin superfamily allows identification of six major subfamilies besides several solitary members11Edited by M. Yaniv","volume":"299","author":"Nollet","year":"2000","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bbrep.2025.102401_bib3","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1083\/jcb.201008173","article-title":"Evolution: structural and functional diversity of cadherin at the adherens junction","volume":"193","author":"Oda","year":"2011","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bbrep.2025.102401_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2023.1137013","article-title":"Cadherins and catenins in cancer: connecting cancer pathways and tumor microenvironment","volume":"11","author":"Lin","year":"2023","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.bbrep.2025.102401_bib5","doi-asserted-by":"crossref","first-page":"989","DOI":"10.3389\/fonc.2019.00989","article-title":"Cadherin signaling in cancer: its functions and role as a therapeutic target","volume":"9","author":"Yu","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbrep.2025.102401_bib6","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cell.2016.06.028","article-title":"EMT: 2016","volume":"166","author":"Nieto","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.bbrep.2025.102401_bib7","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/s41568-021-00332-6","article-title":"Linking EMT programmes to normal and neoplastic epithelial stem cells","volume":"21","author":"Lambert","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbrep.2025.102401_bib8","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.cell.2011.09.024","article-title":"Tumor metastasis: molecular insights and evolving paradigms","volume":"147","author":"Valastyan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.bbrep.2025.102401_bib9","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/s41580-020-0237-9","article-title":"Guidelines and definitions for research on epithelial-mesenchymal transition","volume":"21","author":"Yang","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbrep.2025.102401_bib10","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1083\/jcb.97.3.944","article-title":"Calcium-dependent cell-cell adhesion molecules common to hepatocytes and teratocarcinoma stem cells","volume":"97","author":"Ogou","year":"1983","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bbrep.2025.102401_bib11","doi-asserted-by":"crossref","first-page":"3393","DOI":"10.1002\/j.1460-2075.1985.tb04095.x","article-title":"Identification of a putative cell adhesion domain of uvomorulin","volume":"4","author":"Vestweber","year":"1985","journal-title":"Embo j"},{"key":"10.1016\/j.bbrep.2025.102401_bib12","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.1158\/1078-0432.CCR-12-2747","article-title":"Monoclonal antibody against the ectodomain of E-cadherin (DECMA-1) suppresses breast carcinogenesis: involvement of the HER\/PI3K\/Akt\/mTOR and IAP pathways","volume":"19","author":"Brouxhon","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbrep.2025.102401_bib13","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1097\/PAI.0b013e3182a4edef","article-title":"A new rabbit monoclonal E-cadherin antibody [EP700Y] shows higher sensitivity than mouse monoclonal E-cadherin [HECD-1] antibody in breast ductal carcinomas and does not stain breast lobular carcinomas","volume":"22","author":"Hoang","year":"2014","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"key":"10.1016\/j.bbrep.2025.102401_bib14","article-title":"Development of an anti-CDH15\/M-cadherin monoclonal antibody Ca(15)Mab-1 for flow cytometry, immunoblotting, and immunohistochemistry","volume":"43","author":"Ubukata","year":"2025","journal-title":"Biochem Biophys Rep"},{"key":"10.1016\/j.bbrep.2025.102401_bib15","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1089\/mab.2024.0004","article-title":"Development of a sensitive anti-mouse CCR5 monoclonal antibody for flow cytometry","volume":"43","author":"Suzuki","year":"2024","journal-title":"Monoclon. Antibodies Immunodiagn. Immunother."},{"key":"10.1016\/j.bbrep.2025.102401_bib16","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1089\/mab.2023.0033","article-title":"Establishment of a novel cancer-specific Anti-HER2 monoclonal antibody H(2)Mab-250\/H(2)CasMab-2 for breast cancers","volume":"43","author":"Kaneko","year":"2024","journal-title":"Monoclon. Antibodies Immunodiagn. Immunother."},{"key":"10.1016\/j.bbrep.2025.102401_bib17","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1089\/mab.2017.0042","article-title":"Establishment of EMab-134, a sensitive and specific anti-epidermal growth factor receptor monoclonal antibody for detecting squamous cell carcinoma cells of the oral cavity","volume":"36","author":"Itai","year":"2017","journal-title":"Monoclon. Antibodies Immunodiagn. Immunother."},{"key":"10.1016\/j.bbrep.2025.102401_bib18","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.pep.2014.01.009","article-title":"PA tag: a versatile protein tagging system using a super high affinity antibody against a dodecapeptide derived from human podoplanin","volume":"95","author":"Fujii","year":"2014","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.bbrep.2025.102401_bib31","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s12943-019-1043-x","article-title":"Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA","volume":"18","author":"Ye","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbrep.2025.102401_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.109363","article-title":"Overcoming antibody-resistant SARS-CoV-2 variants with bispecific antibodies constructed using non-neutralizing antibodies","volume":"27","author":"Inoue","year":"2024","journal-title":"iScience"},{"key":"10.1016\/j.bbrep.2025.102401_bib20","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1089\/mab.2023.0015","article-title":"Development of an Anti-EphB4 monoclonal antibody for multiple applications against breast cancers","volume":"42","author":"Nanamiya","year":"2023","journal-title":"Monoclon. Antibodies Immunodiagn. Immunother."},{"key":"10.1016\/j.bbrep.2025.102401_bib21","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/cam4.347","article-title":"\u03b4EF1 associates with DNMT1 and maintains DNA methylation of the E-cadherin promoter in breast cancer cells","volume":"4","author":"Fukagawa","year":"2015","journal-title":"Cancer Med."},{"key":"10.1016\/j.bbrep.2025.102401_bib22","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a003053","article-title":"Structure and biochemistry of cadherins and catenins","volume":"1","author":"Shapiro","year":"2009","journal-title":"Cold Spring Harbor Perspect. Biol."},{"key":"10.1016\/j.bbrep.2025.102401_bib23","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/s41392-024-01938-6","article-title":"Circulating tumor cells: from new biological insights to clinical practice","volume":"9","author":"Gu","year":"2024","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.bbrep.2025.102401_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104237","article-title":"Circulating tumor cell isolation for cancer diagnosis and prognosis","volume":"83","author":"Deng","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.bbrep.2025.102401_bib25","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s10555-020-09898-3","article-title":"Expression and function of epithelial cell adhesion molecule EpCAM: where are we after 40 years?","volume":"39","author":"Gires","year":"2020","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.bbrep.2025.102401_bib26","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nrurol.2016.224","article-title":"Circulating tumour cells as biomarkers of prostate, bladder, and kidney cancer","volume":"14","author":"Gorin","year":"2017","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.bbrep.2025.102401_bib27","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1097\/CCO.0b013e32833de186","article-title":"Circulating tumor cells and emerging blood biomarkers in breast cancer","volume":"22","author":"Criscitiello","year":"2010","journal-title":"Curr. Opin. Oncol."},{"key":"10.1016\/j.bbrep.2025.102401_bib28","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.mam.2019.06.002","article-title":"Circulating biomarkers for early detection and clinical management of colorectal cancer","volume":"69","author":"Marcuello","year":"2019","journal-title":"Mol. Aspect. Med."},{"key":"10.1016\/j.bbrep.2025.102401_bib29","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.7150\/thno.28745","article-title":"Microfluidic isolation of circulating tumor cells and cancer stem-like cells from patients with pancreatic ductal adenocarcinoma","volume":"9","author":"Varillas","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.bbrep.2025.102401_bib30","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1021\/acs.nanolett.0c04180","article-title":"In vivo coinstantaneous identification of hepatocellular carcinoma circulating tumor cells by dual-targeting magnetic-fluorescent nanobeads","volume":"21","author":"Xia","year":"2021","journal-title":"Nano Lett."},{"key":"10.1016\/j.bbrep.2025.102401_bib32","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ajpath.2018.03.020","article-title":"Circulating tumor cells and cell-free DNA in pancreatic ductal adenocarcinoma","volume":"189","author":"Gall","year":"2019","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbrep.2025.102401_bib33","doi-asserted-by":"crossref","first-page":"16787","DOI":"10.1021\/acs.analchem.1c03167","article-title":"Dynamic monitoring of EMT in CTCs as an indicator of cancer metastasis","volume":"93","author":"Zhang","year":"2021","journal-title":"Anal. Chem."},{"key":"10.1016\/j.bbrep.2025.102401_bib34","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.trecan.2021.07.001","article-title":"Better together: circulating tumor cell clustering in metastatic cancer","volume":"7","author":"Schuster","year":"2021","journal-title":"Trends Cancer"},{"key":"10.1016\/j.bbrep.2025.102401_bib35","doi-asserted-by":"crossref","first-page":"3649","DOI":"10.1158\/0008-5472.CAN-20-1799","article-title":"Phenotypic heterogeneity and metastasis of breast cancer cells","volume":"81","author":"Hapach","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrep.2025.102401_bib36","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nrc3647","article-title":"Beyond E-cadherin: roles of other cadherin superfamily members in cancer","volume":"14","author":"van Roy","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbrep.2025.102401_bib37","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.bbrep.2025.102401_bib38","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1016\/j.devcel.2021.11.006","article-title":"Distinct contributions of partial and full EMT to breast cancer malignancy","volume":"56","author":"L\u00fc\u00f6nd","year":"2021","journal-title":"Dev. Cell"},{"key":"10.1016\/j.bbrep.2025.102401_bib39","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s10549-013-2415-3","article-title":"Loss of E-cadherin is not a necessity for epithelial to mesenchymal transition in human breast cancer","volume":"138","author":"Hollestelle","year":"2013","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.bbrep.2025.102401_bib40","doi-asserted-by":"crossref","first-page":"6574","DOI":"10.1038\/s41598-018-23733-4","article-title":"E-cadherin breast tumor expression, risk factors and survival: pooled analysis of 5,933 cases from 12 studies in the breast cancer association consortium","volume":"8","author":"Horne","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrep.2025.102401_bib41","first-page":"23","article-title":"E-cadherin's dark side: possible role in tumor progression","volume":"1826","author":"Rodriguez","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbrep.2025.102401_bib42","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1126\/science.aaf6546","article-title":"A collective route to metastasis: seeding by tumor cell clusters","volume":"352","author":"Cheung","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.bbrep.2025.102401_bib43","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1016\/j.cell.2013.11.029","article-title":"Collective invasion in breast cancer requires a conserved basal epithelial program","volume":"155","author":"Cheung","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.bbrep.2025.102401_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.102113","article-title":"Interplay between tumor microenvironment and partial EMT as the driver of tumor progression","volume":"24","author":"Aggarwal","year":"2021","journal-title":"iScience"},{"key":"10.1016\/j.bbrep.2025.102401_bib45","doi-asserted-by":"crossref","first-page":"5436","DOI":"10.1016\/j.cell.2025.08.033","article-title":"Epithelial-mesenchymal transition","volume":"188","author":"Zhang","year":"2025","journal-title":"Cell"},{"key":"10.1016\/j.bbrep.2025.102401_bib46","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/s41586-019-1526-3","article-title":"E-cadherin is required for metastasis in multiple models of breast cancer","volume":"573","author":"Padmanaban","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.bbrep.2025.102401_bib47","doi-asserted-by":"crossref","first-page":"5931","DOI":"10.1073\/pnas.1918167117","article-title":"The functional activity of E-cadherin controls tumor cell metastasis at multiple steps","volume":"117","author":"Na","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrep.2025.102401_bib48","doi-asserted-by":"crossref","DOI":"10.3390\/cells13221833","article-title":"A cancer-specific anti-podoplanin monoclonal antibody, PMab-117-mG(2a) exerts antitumor activities in human tumor xenograft models","volume":"13","author":"Tanaka","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.bbrep.2025.102401_bib49","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25031941","article-title":"A cancer-specific monoclonal antibody against HER2 exerts antitumor activities in human breast cancer xenograft models","volume":"25","author":"Kaneko","year":"2024","journal-title":"Int. J. Mol. Sci."}],"container-title":["Biochemistry and Biophysics Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405580825004881?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405580825004881?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T06:13:30Z","timestamp":1773900810000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405580825004881"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":49,"alternative-id":["S2405580825004881"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrep.2025.102401","relation":{},"ISSN":["2405-5808"],"issn-type":[{"value":"2405-5808","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of novel anti-CDH1\/E-cadherin monoclonal antibodies for versatile applications","name":"articletitle","label":"Article Title"},{"value":"Biochemistry and Biophysics Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrep.2025.102401","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102401"}}